Dr. Noga Harizman, MD

Dr. Harizman practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Harizman's NPI, 1588697908, was assigned on July 9, 2006. Dr. Harizman graduated from Tel Aviv University Sackler in 1998. Dr. Harizman holds New York license P40617.

Dr. Harizman's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Harizman's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Harizman is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Harizman to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harizman practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Harizman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Harizman is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Harizman is licensed in New York.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and secondary membranaous cataract surgery among the conditions Dr. Harizman treats.

CMS data shows 2,829 Medicare services from Dr. Harizman across 15 procedure codes in 2024, for 661 Medicare patients. Medicare paid $176,526 for them.

CMS counts 661 Medicare patients who saw Dr. Harizman in 2024. The largest group is 75 to 84, with 296 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harizman's median patient age at 71, with 59% women.

In 2024, Dr. Harizman wrote 2,684 Medicare Part D claims for 466 patients. 61% of them were for generic drugs. CMS names the drug for 2,558 of them, across 23 drugs with 11 or more claims each, at $323,835 in total drug cost. In 2023, CMS named 2,895 claims across 27 drugs.

Dr. Harizman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 103 procedures of cataract surgery by Dr. Harizman, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Harizman, published from 2020 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Glaucoma, Intraocular Pressure and Vision Screening. Dr. Harizman has published most often in J Glaucoma. Dr. Harizman's most frequent co-authors are George A. Cioffi, MD, Jeffrey M. Liebmann, MD and Qing Wang, MD, PhD.

Dmand AI links Dr. Harizman to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Blindness, Glaucoma and Diabetic Retinopathy.

CMS Open Payments shows 59 general payments to Dr. Harizman from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. New World Medical,inc. paid the most, $3,206.

Dr. Harizman graduated from Tel Aviv University Sackler in 1998.

Dr. Harizman is in network with 17 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.